Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$33.4 - $45.2 $14,128 - $19,119
423 Added 7.42%
6,122 $217,000
Q3 2023

Nov 13, 2023

BUY
$37.8 - $45.97 $982 - $1,195
26 Added 0.46%
5,699 $217,000
Q2 2023

Aug 08, 2023

SELL
$37.95 - $58.98 $8,804 - $13,683
-232 Reduced 3.93%
5,673 $233,000
Q1 2023

May 11, 2023

SELL
$52.61 - $60.49 $48,138 - $55,348
-915 Reduced 13.42%
5,905 $339,000
Q4 2022

Feb 06, 2023

BUY
$42.17 - $58.6 $9,150 - $12,716
217 Added 3.29%
6,820 $382,000
Q3 2022

Oct 27, 2022

SELL
$42.28 - $57.17 $20,759 - $28,070
-491 Reduced 6.92%
6,603 $283,000
Q2 2022

Aug 10, 2022

BUY
$53.86 - $66.52 $8,186 - $10,111
152 Added 2.19%
7,094 $376,000
Q1 2022

May 12, 2022

BUY
$62.86 - $69.24 $251 - $276
4 Added 0.06%
6,942 $449,000
Q4 2021

Feb 14, 2022

BUY
$62.47 - $73.25 $6,996 - $8,204
112 Added 1.64%
6,938 $457,000
Q3 2021

Nov 08, 2021

SELL
$64.97 - $76.19 $200,562 - $235,198
-3,087 Reduced 31.14%
6,826 $466,000
Q2 2021

Aug 11, 2021

BUY
$66.79 - $76.63 $7,012 - $8,046
105 Added 1.07%
9,913 $678,000
Q1 2021

May 11, 2021

BUY
$62.63 - $71.15 $9,895 - $11,241
158 Added 1.64%
9,808 $677,000
Q4 2020

Feb 11, 2021

BUY
$43.31 - $66.55 $36,596 - $56,234
845 Added 9.6%
9,650 $628,000
Q3 2020

Nov 09, 2020

BUY
$43.33 - $51.72 $12,479 - $14,895
288 Added 3.38%
8,805 $417,000
Q2 2020

Aug 10, 2020

BUY
$41.42 - $55.57 $662 - $889
16 Added 0.19%
8,517 $400,000
Q1 2020

Apr 24, 2020

BUY
$36.67 - $61.04 $16,648 - $27,712
454 Added 5.64%
8,501 $377,000
Q4 2019

Feb 06, 2020

SELL
$55.73 - $62.49 $62,696 - $70,301
-1,125 Reduced 12.27%
8,047 $473,000
Q3 2019

Nov 01, 2019

BUY
$53.29 - $64.59 $488,775 - $592,419
9,172 New
9,172 $553,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.